The policy defines in vitro diagnostic (IVD) device, and describes FDA Guidance stating FDA will exercise enforcement discretion with respect to its current regulations governing the requirement for informed consent when human specimens, not individually identifiable, are used for FDA regulated in vitro diagnostic device investigations.